Company / Revenue
FILANA THERAPEUTICS, INC. Revenue History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$41.1M
FY2015
5-year range
$10.9M / $41.1M
FY2011-FY2015
Trend
+277.6%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue changed +278% YoY in FY2015, a notable deviation from the 4-year average annual change of +56%.
Based on SEC 10-K filings.
$41M in FY2015 with a 3-year CAGR of +34.7%.
Improved from $11M to $41M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +34.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +34.7%, indicating consistent growth.
- In FY2015, revenue increased 277.6% year-over-year.
- Lowest revenue in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $41.1M | +277.6% |
| FY2014 | $10.9M | -5.2% |
| FY2013 | $11.5M | -31.7% |
| FY2012 | $16.8M | -18.3% |
| FY2011 | $20.6M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026